Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of Jan 21. </li>
<li>Top short increases and decreases were tabulated for one week and four week period. </li>
<li>We highlight short increases in AIA (1299 HK) and Country Garden (2007 HK). </li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of Jan 21. 
Top short increases and decreases were tabulated for one week and four week period. 
We highlight short increases in AIA (1299 HK) and Country Garden (2007 HK). 


Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

Equity Capital Markets

Beijing Yuanxin Technology Group Co Ltd / Equity Capital Markets

<ul>
<li>Beijing Yuanxin Tech (BYT) is looking to raise US$500m in its upcoming Hong Kong IPO.</li>
<li>As per F&amp;S, the firm is the No. 1 integrated healthcare fulfilment platform in China focusing on prescription drugs</li>
<li>In this note, we look at the company’s fundamentals and operations and share our thoughts about the IPO.</li>
</ul>


Beijing Yuanxin Tech (BYT) is looking to raise US$500m in its upcoming Hong Kong IPO.
As per F&amp;S, the firm is the No. 1 integrated healthcare fulfilment platform in China focusing on prescription drugs
In this note, we look at the company’s fundamentals and operations and share our thoughts about the IPO.


Beijing Yuanxin (北京圆心) Pre-IPO - Growing at the Expense of Margins

<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of Jan 14. </li>
<li>Top short increases and decreases were tabulated for one week and four week period. </li>
<li>We highlight the short interest increases for HSBC and Wuxi Biologics in the latest short report.</li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of Jan 14. 
Top short increases and decreases were tabulated for one week and four week period. 
We highlight the short interest increases for HSBC and Wuxi Biologics in the latest short report.


<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of Jan 7th. </li>
<li>Top short increases and decreases were tabulated for one week and four week period. </li>
<li>We highlight short spike for Alibaba (9988 HK) and China Overseas Land (688 HK).</li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of Jan 7th. 
Top short increases and decreases were tabulated for one week and four week period. 
We highlight short spike for Alibaba (9988 HK) and China Overseas Land (688 HK).


HK Short Interest: Alibaba, China Overseas Land

Silver Point

Thomas J. Monaco

Independent Insight Provider

Silver Point is a boutique research firm that focuses on the broader financial services sector, with a particular focus on troubled institutions globally. 

Asia Ex Japan

Equity Bottom-Up

China Merchants Bank H / Equity Bottom-Up

<ul>
<li>
Competitor Call Reveals Numerous Additional Risks Which Will Weigh On Results. </li>
<li>No Clarity On Go Forward Core Bottom-Line, Especially Gains and Loss Provisions. </li>
<li>Reserve to NPLs Looks Overstated, as WMP and Securities Are Included In Loan Reserves. </li>
</ul>



Competitor Call Reveals Numerous Additional Risks Which Will Weigh On Results. 
No Clarity On Go Forward Core Bottom-Line, Especially Gains and Loss Provisions. 
Reserve to NPLs Looks Overstated, as WMP and Securities Are Included In Loan Reserves. 


China Merchants Bank – Accelerating Risk

China

Ping An Insurance (Group) Company of China Limited provides products and services through its five ecosystems in financial services, healthcare, auto services, real estate services and Smart City solutions. The Group's insurance business writes property, casualty, and life insurance products.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Ping An Insurance Group of (601318 CH)

HK Short Interest: AIA, Country Garden

We highlight week on week short increases in AIA (1299 HK) and Country Garden (2007 HK) in the latest Hong Kong SFC short aggregate report.

Ke Yan, CFA, FRM

Beijing Yuanxin (北京圆心) Pre-IPO - Growing at the Expense of Margins

Beijing Yuanxin Tech (BYT) is looking to raise US$500m in its upcoming Hong Kong IPO. In this note, we look at the company's past performance.

Sumeet Singh

HK Short Interest: HSBC, Wuxi Biologics

We highlight the week on week short interest increases for HSBC (5 HK) and Wuxi Biologics (2269 HK) in the latest Hong Kong SFC aggregate short...

Ke Yan, CFA, FRM

HK Short Interest: Alibaba, China Overseas Land

We highlight week on week short spike for Alibaba (9988 HK) and China Overseas Land (688 HK) from the latest SFC short aggregate report.

Ke Yan, CFA, FRM

China Merchants Bank – Accelerating Risk

CHINA MERCHANTS BANK: A discussion over the use of gains and a drop in loss provisions during 3Q21 would have been a better use of time. CMB’s core...

Thomas J. Monaco

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)